This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Ono Pharmaceutical Co., Ltd., Tokushima University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 575 
1 out of 42 
Years Active: 2025
Title: Daisuke Sugiura: Innovator in Immunosuppressive Agents
Introduction
Daisuke Sugiura is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of immunology, particularly through his innovative work on immunosuppressive agents. His research focuses on enhancing the effectiveness of treatments that modulate immune responses.
Latest Patents
Daisuke Sugiura holds a patent for an immunosuppressive agent. This agent contains a substance selected from anti-CD80 antibodies and anti-PD-L1 antibodies, which promotes binding between PD-L1 and PD-1. This innovative approach has the potential to improve therapeutic strategies in various medical applications.
Career Highlights
Throughout his career, Daisuke has worked with prominent organizations, including Ono Pharmaceutical Co., Ltd. and Tokushima University. His experience in these institutions has allowed him to advance his research and contribute to the development of new medical therapies.
Collaborations
Daisuke has collaborated with esteemed colleagues such as Taku Okazaki and Takeo Maeda. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Daisuke Sugiura's work in the field of immunosuppressive agents exemplifies the importance of innovation in medical research. His contributions are paving the way for advancements in immunotherapy and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile